Summary & Overview
HCPCS J3010: Injection, Fentanyl Citrate, 0.1 mg
HCPCS Level II code J3010 denotes the injection of fentanyl citrate, 0.1 mg, an opioid analgesic used for rapid-onset management of severe pain. Nationally, accurate reporting of this HCPCS code matters for inpatient and outpatient facility billing, controlled substance tracking, and cost benchmarking for acute analgesia. Proper coding affects payment reconciliation and clinical documentation across acute care settings.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for parenteral fentanyl use, common sites of service where J3010 applies, and benchmarking and policy topics relevant to payers and providers. The publication outlines typical billing practices, potential coding pitfalls, and the landscape of payer coverage and coding guidance at a national level.
This summary equips coding professionals, revenue cycle managers, and clinicians with the foundational information needed to understand where J3010 fits in billing workflows, what documentation aligns with injectable opioid administration, and which commercial and federal payers commonly appear in reimbursement discussions. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J3010 represents an injection of fentanyl citrate, 0.1 mg. The service is an administered injectable opioid analgesic typically used for the management of severe pain when rapid-onset opioid therapy is indicated. The service type is an injectable medication administration. The typical site of service includes hospital inpatient, hospital outpatient, emergency department, and ambulatory surgical or procedural settings where parenteral opioid administration is provided.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient surgical center or hospital procedural unit requiring procedural analgesia or anesthesia for a painful intervention. Typical scenarios include short, painful procedures such as wound debridement, burn care, dental extraction in a medically complex patient, or anesthesia adjunct for minor surgical procedures. The medication is supplied as J3010 (Injection, fentanyl citrate, 0.1 mg) and is administered intravenously by a licensed clinician (anesthesiologist, nurse anesthetist, or intensivist) as part of monitored anesthesia care (MAC) or general anesthesia.
A typical workflow: the patient arrives for the scheduled procedure; pre-procedure assessment documents indication, allergies, airway evaluation, and concurrent medications. Standard monitoring (pulse oximetry, blood pressure, ECG, capnography if sedated) is applied. A clinician draws and doses the fentanyl citrate according to weight and clinical needs; documentation records the drug name, J3010 billing unit(s), dose administered, route (intravenous), time, and administering clinician. Post-procedure recovery includes monitoring for respiratory depression, sedation level, and pain control before discharge or transfer to an inpatient bed. Billing uses J3010 with appropriate units and may add modifiers per payer rules to indicate aspects such as professional service, NCCI-related circumstances, or provider specialty.
Coding Specifications
| Modifier | Description | When to Use |
|---|